Current Stem Cell Research and Therapy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Monocytic Barrier to the Humanization of Immunodeficient Mice
Curr Stem Cell Res Ther. 2023 Oct 6. doi: 10.2174/011574888X263597231001164351. Online ahead of print.ABSTRACTMice with severe immunodeficiencies have become very important tools for studying foreign cells in an in vivo environment. Xenotransplants can be used to model cells from many species, although most often, mice are humanized through the transplantation of human cells or tissues to meet the needs of medical research. The development of immunodeficient mice is reviewed leading up to the current state-of-the-art strains, such as the NOD-scid-gamma (NSG) mouse. NSG mice are excellent hosts for human hematopoietic stem ...
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Emily Du Marcus Muench Source Type: research

RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/ β-catenin Signaling Pathway
CONCLUSION: RHBDD1 is highly expressed in GC, and its knockdown inhibits the growth, metastasis and stemness characteristics of GC cells through activating the Wnt/β-catenin pathway, suggesting that RHBDD1 has the potential to be a novel therapeutic target for GC treatment.PMID:37861049 | DOI:10.2174/011574888X259932231010112521 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Yingxue Yang Yuan Yuan Boning Xia Source Type: research

In-vitro Augmentation of Mesenchymal Stem Cells by Using Adult Bovine Serum
CONCLUSION: Intriguingly, ABS proved to be an effective supplement in the growth medium for expanding UC-MSCs in vitro, providing a viable alternative to FBS.PMID:37861050 | DOI:10.2174/011574888X260118230927050143 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Somia Shehzadi Maryam Javed Asmat Ullah Ahmad Bilal Waqar Fatima Iftikhar Shah Sajjad Ullah Source Type: research

A Monocytic Barrier to the Humanization of Immunodeficient Mice
Curr Stem Cell Res Ther. 2023 Oct 6. doi: 10.2174/011574888X263597231001164351. Online ahead of print.ABSTRACTMice with severe immunodeficiencies have become very important tools for studying foreign cells in an in vivo environment. Xenotransplants can be used to model cells from many species, although most often, mice are humanized through the transplantation of human cells or tissues to meet the needs of medical research. The development of immunodeficient mice is reviewed leading up to the current state-of-the-art strains, such as the NOD-scid-gamma (NSG) mouse. NSG mice are excellent hosts for human hematopoietic stem ...
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Emily Du Marcus Muench Source Type: research

RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/ β-catenin Signaling Pathway
CONCLUSION: RHBDD1 is highly expressed in GC, and its knockdown inhibits the growth, metastasis and stemness characteristics of GC cells through activating the Wnt/β-catenin pathway, suggesting that RHBDD1 has the potential to be a novel therapeutic target for GC treatment.PMID:37861049 | DOI:10.2174/011574888X259932231010112521 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Yingxue Yang Yuan Yuan Boning Xia Source Type: research

In-vitro Augmentation of Mesenchymal Stem Cells by Using Adult Bovine Serum
CONCLUSION: Intriguingly, ABS proved to be an effective supplement in the growth medium for expanding UC-MSCs in vitro, providing a viable alternative to FBS.PMID:37861050 | DOI:10.2174/011574888X260118230927050143 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Somia Shehzadi Maryam Javed Asmat Ullah Ahmad Bilal Waqar Fatima Iftikhar Shah Sajjad Ullah Source Type: research

A Monocytic Barrier to the Humanization of Immunodeficient Mice
Curr Stem Cell Res Ther. 2023 Oct 6. doi: 10.2174/011574888X263597231001164351. Online ahead of print.ABSTRACTMice with severe immunodeficiencies have become very important tools for studying foreign cells in an in vivo environment. Xenotransplants can be used to model cells from many species, although most often, mice are humanized through the transplantation of human cells or tissues to meet the needs of medical research. The development of immunodeficient mice is reviewed leading up to the current state-of-the-art strains, such as the NOD-scid-gamma (NSG) mouse. NSG mice are excellent hosts for human hematopoietic stem ...
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Emily Du Marcus Muench Source Type: research

RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/ β-catenin Signaling Pathway
CONCLUSION: RHBDD1 is highly expressed in GC, and its knockdown inhibits the growth, metastasis and stemness characteristics of GC cells through activating the Wnt/β-catenin pathway, suggesting that RHBDD1 has the potential to be a novel therapeutic target for GC treatment.PMID:37861049 | DOI:10.2174/011574888X259932231010112521 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Yingxue Yang Yuan Yuan Boning Xia Source Type: research

In-vitro Augmentation of Mesenchymal Stem Cells by Using Adult Bovine Serum
CONCLUSION: Intriguingly, ABS proved to be an effective supplement in the growth medium for expanding UC-MSCs in vitro, providing a viable alternative to FBS.PMID:37861050 | DOI:10.2174/011574888X260118230927050143 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Somia Shehzadi Maryam Javed Asmat Ullah Ahmad Bilal Waqar Fatima Iftikhar Shah Sajjad Ullah Source Type: research

A Monocytic Barrier to the Humanization of Immunodeficient Mice
Curr Stem Cell Res Ther. 2023 Oct 6. doi: 10.2174/011574888X263597231001164351. Online ahead of print.ABSTRACTMice with severe immunodeficiencies have become very important tools for studying foreign cells in an in vivo environment. Xenotransplants can be used to model cells from many species, although most often, mice are humanized through the transplantation of human cells or tissues to meet the needs of medical research. The development of immunodeficient mice is reviewed leading up to the current state-of-the-art strains, such as the NOD-scid-gamma (NSG) mouse. NSG mice are excellent hosts for human hematopoietic stem ...
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Emily Du Marcus Muench Source Type: research

RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/ β-catenin Signaling Pathway
CONCLUSION: RHBDD1 is highly expressed in GC, and its knockdown inhibits the growth, metastasis and stemness characteristics of GC cells through activating the Wnt/β-catenin pathway, suggesting that RHBDD1 has the potential to be a novel therapeutic target for GC treatment.PMID:37861049 | DOI:10.2174/011574888X259932231010112521 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Yingxue Yang Yuan Yuan Boning Xia Source Type: research

In-vitro Augmentation of Mesenchymal Stem Cells by Using Adult Bovine Serum
CONCLUSION: Intriguingly, ABS proved to be an effective supplement in the growth medium for expanding UC-MSCs in vitro, providing a viable alternative to FBS.PMID:37861050 | DOI:10.2174/011574888X260118230927050143 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Somia Shehzadi Maryam Javed Asmat Ullah Ahmad Bilal Waqar Fatima Iftikhar Shah Sajjad Ullah Source Type: research

A Monocytic Barrier to the Humanization of Immunodeficient Mice
Curr Stem Cell Res Ther. 2023 Oct 6. doi: 10.2174/011574888X263597231001164351. Online ahead of print.ABSTRACTMice with severe immunodeficiencies have become very important tools for studying foreign cells in an in vivo environment. Xenotransplants can be used to model cells from many species, although most often, mice are humanized through the transplantation of human cells or tissues to meet the needs of medical research. The development of immunodeficient mice is reviewed leading up to the current state-of-the-art strains, such as the NOD-scid-gamma (NSG) mouse. NSG mice are excellent hosts for human hematopoietic stem ...
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Emily Du Marcus Muench Source Type: research

RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/ β-catenin Signaling Pathway
CONCLUSION: RHBDD1 is highly expressed in GC, and its knockdown inhibits the growth, metastasis and stemness characteristics of GC cells through activating the Wnt/β-catenin pathway, suggesting that RHBDD1 has the potential to be a novel therapeutic target for GC treatment.PMID:37861049 | DOI:10.2174/011574888X259932231010112521 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Yingxue Yang Yuan Yuan Boning Xia Source Type: research

In-vitro Augmentation of Mesenchymal Stem Cells by Using Adult Bovine Serum
CONCLUSION: Intriguingly, ABS proved to be an effective supplement in the growth medium for expanding UC-MSCs in vitro, providing a viable alternative to FBS.PMID:37861050 | DOI:10.2174/011574888X260118230927050143 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - October 20, 2023 Category: Stem Cells Authors: Somia Shehzadi Maryam Javed Asmat Ullah Ahmad Bilal Waqar Fatima Iftikhar Shah Sajjad Ullah Source Type: research